Drug recall

DDAVP Nasal Spray (desmopressin acetate) 10 mcg/0.1 mL, 5 mL bottles, Rx Only, Mfd for: Ferring…

FDA recall event 86066 · Class I · Ferring Pharmaceuticals Inc

Key facts

Event ID 86066
Recall numbers D-1504-2020, D-1505-2020, D-1506-2020
Recalling firm Ferring Pharmaceuticals Inc
Product type Drugs
Products DDAVP Nasal Spray (desmopressin acetate) 10 mcg/0.1 mL, 5 mL bottles, Rx Only, Mfd for: Ferring Pharmaceuticals Inc., Parsippany, NJ 07054 USA, NDC 55566-2500-0, Desmopressin Acetate Nasal Spray 10 mcg/0.1 mL, 5mL glass vial with spray cap, Rx only, Manufactured for: AMRING PHARMACEUTICALS INC., Berwyn, PA 19312, NDC 69918-501-05, STIMATE (desmopressin acetate) Nasal Spray1.5 mg/mL, 2.5 mL glass vial with spray cap, Rx only, Manufactured for: CSL Behring LLC, King of Prussia, PA 19406-0901; By: Ferring GmbH, Kiel, Germany, NDC…
Classification Class I
Status Terminated
Voluntary or mandated Voluntary: Firm Initiated
Reason for recall Superpotent Drug
Initiation date Jul 21, 2020
Report date Aug 26, 2020
Termination date Oct 13, 2023
City Parsippany
State NJ
Country United States
FEI number 1000119907

At a glance

  • 1–9 Products in this recall
  • None FDA inspections of this firm (FEI)

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA drug and product recalls

FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.

Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date:

Browse all FDA drug and product recalls